SARS-CoV-2 can mutate and evade immunity, with consequences for efficacy of emerging
vaccines and antibody therapeutics. Here, we demonstrate that the immunodominant SARS-…

Background There are thousands of survivors of the 2014 Ebola outbreak in west Africa.
Ebola virus can persist in survivors for months in immune-privileged sites; however, viral …

Coronavirus disease 2019 (COVID-19) was first diagnosed in Scotland on 1 March 2020.
During the first month of the outbreak, 2,641 cases of COVID-19 led to 1,832 hospital …

SARS-CoV-2 can mutate to evade immunity, with consequences for the efficacy of emerging
vaccines and antibody therapeutics. Herein we demonstrate that the immunodominant …

Affordable next-generation sequencing (NGS) technologies for hepatitis C virus (HCV) may
potentially identify both viral genotype and resistance genetic motifs in the era of directly …

The small interfering RNA (siRNA) pathway is a major antiviral response in mosquitoes;
however, another RNA interference pathway, the PIWI-interacting RNA (piRNA) pathway, has …

The genomic characteristics of human cytomegalovirus (HCMV) strains sequenced directly
from clinical pathology samples were investigated, focusing on variation, multiple-strain …

RNA interference (RNAi) controls arbovirus infections in mosquitoes. Two different RNAi
pathways are involved in antiviral responses: the PIWI-interacting RNA (piRNA) and exogenous …

Human coxsackievirus A6 (CVA6) is an enterically transmitted enterovirus. Until recently,
CVA6 infections were considered as being of minor clinical significance, and only rarely …

Objectives Travel-associated infections are challenging to diagnose because of the broad
spectrum of potential aetiologies. As a proof-of-principle study, we used MNGS to identify viral …